重编程患者诱导的多能干细胞特异性视网膜器官,以破译RNA甲基化的表观遗传修饰
Yueh Chien1, Yi-Ping Yang1, Tai-Chi Lin1,2,3
1Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Journal of the Chinese Medical Association : JCMA
|December 23, 2024
概括
通过使用患者衍生的视网膜器官来研究勒伯遗传性视神经病变 (LHON) 中的N6-甲基亚丁素 (m6A) 修饰,揭示了m6A通路的破坏. 这些表观遗传变化与视网膜神经退行性疾病的发病有关.
科学领域:
- 干细胞生物学 干细胞生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 神经科学是一个神经科学.
背景情况:
- 诱导多能干细胞 (iPSC) 和iPSC衍生器官为研究视网膜神经退行性疾病提供了患者特异性模型.
- N6-甲基氨酸 (m6A) 是一种关键的RNA修饰,参与各种RNA代谢过程.
- 线粒体功能障碍及其后果是视网膜神经退行性疾病的核心,但潜在的表观遗传机制尚不清楚.
研究的目的:
- 为了研究m6A修饰在视网膜神经退行性疾病中的作用,使用患者特定的iPSC衍生的视网膜器官.
- 探索表观遗传机制,特别是m6A通路,有助于莱伯遗传性视神经病变 (LHON) 的发病.
主要方法:
- 从患有LHON.的个体生成患者特异性的iPSCs.
- 在视网膜有机体内分化的iPSC变成视网膜质细胞 (RGC).
- 通过定量PCR分析m6A甲基化,专注于m6A修饰酶的差异表达.
主要成果:
- 确立了iPSC衍生的视网膜有机体,作为研究视网膜神经退行性疾病表观遗传机制的可行模型.
- 在LHON患者衍生的iPSC-RGC中分析了全球m6A相关基因表达.
- 与对照组相比,在LHON患者细胞中确定了m6A修饰途径的特定干扰.
结论:
- 建议差异性m6A修饰在视网膜神经退行性疾病的发病过程中发挥重要作用.
- 这些表观遗传变化可能会影响受影响个体的疾病进展.
- 来自iPSC的视网膜器官对于研究这些表观遗传贡献非常有价值.
更多相关视频
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.5K
09:47Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
3.3K
相关概念视频
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:32Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K